Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress — Stella

Home/Prematurity/Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress

View on ClinicalTrials.gov

Recruiting

Back to Prematurity trials

Caffeine as an Adjuvant Therapy for Late Preterm Infants With Respiratory Distress

Phase 2 — Testing in a larger group (up to a few hundred people) to further evaluate safety and begin to assess effectiveness.

Trial locations(2 sites)

Saudi Arabia

King Salman Bin Abdulaziz Medical City, Madinah, Medina Region

King Salman Bin Abdulaziz Medical City, Madinah

Key details

Phase

Safety & dosing / Large-scale testing

Sponsor

Ministry of Health, Saudi Arabia

Enrollment target

~134 participants

Started

October 2023

Primary completion

October 2027

Age range

1 Day – 3 Days

Last updated June 2025

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.